| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant Therapy in Patients With Completely Resected Non–small-cell Lung Cancer: Current Status and Perspectives
|
Pirker, Robert
|
|
2019
|
20 |
1 |
p. 1-6
|
artikel
|
| 2 |
Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer Patients
|
Grass, G. Daniel
|
|
2019
|
20 |
1 |
p. e1-e7
|
artikel
|
| 3 |
A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non–small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L)
|
Akamatsu, Hiroaki
|
|
2019
|
20 |
1 |
p. e25-e27
|
artikel
|
| 4 |
Editorial Board
|
|
|
2019
|
20 |
1 |
p. A4
|
artikel
|
| 5 |
Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations
|
Hu, Fang
|
|
2019
|
20 |
1 |
p. e81-e90
|
artikel
|
| 6 |
Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis
|
Ksienski, Doran
|
|
2019
|
20 |
1 |
p. e97-e106
|
artikel
|
| 7 |
Elective Nodal Irradiation as Adjuvant Radiotherapy for Advanced Thymomas and Thymic Carcinomas
|
Kim, Yeon Joo
|
|
2019
|
20 |
1 |
p. e91-e96
|
artikel
|
| 8 |
Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer
|
Chang, Hyun
|
|
2019
|
20 |
1 |
p. 7-12.e1
|
artikel
|
| 9 |
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location
|
Schonewolf, Caitlin A.
|
|
2019
|
20 |
1 |
p. e63-e71
|
artikel
|
| 10 |
Immune Microenvironment Differences Between Squamous and Non-squamous Non–small-cell Lung Cancer and Their Influence on the Prognosis
|
Meng, Xiangjiao
|
|
2019
|
20 |
1 |
p. 48-58
|
artikel
|
| 11 |
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)
|
Elamin, Yasir Y.
|
|
2019
|
20 |
1 |
p. 43-47
|
artikel
|
| 12 |
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non–small-cell Lung Cancer at Diagnosis
|
Rice, Stephanie R.
|
|
2019
|
20 |
1 |
p. e107-e114
|
artikel
|
| 13 |
Moderately Hypofractionated Helical IMRT, FDG–PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
|
Fodor, Andrei
|
|
2019
|
20 |
1 |
p. e29-e38
|
artikel
|
| 14 |
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer
|
Kim, Eun Kyung
|
|
2019
|
20 |
1 |
p. e123-e132
|
artikel
|
| 15 |
Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non–Small-cell Lung Cancer: A Single-center Analysis
|
Yu, Tiffany M.
|
|
2019
|
20 |
1 |
p. 20-29.e8
|
artikel
|
| 16 |
Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program
|
Raz, Dan J.
|
|
2019
|
20 |
1 |
p. e115-e122
|
artikel
|
| 17 |
Predictors of Distant Failure After Stereotactic Body Radiation Therapy for Stages I to IIA Non–Small-Cell Lung Cancer
|
Miller, Chelsea J.
|
|
2019
|
20 |
1 |
p. 37-42
|
artikel
|
| 18 |
Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib
|
Ng, Terry L.
|
|
2019
|
20 |
1 |
p. e39-e51
|
artikel
|
| 19 |
Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns
|
Farrell, Matthew J.
|
|
2019
|
20 |
1 |
p. 13-19
|
artikel
|
| 20 |
Severe Acute Hepatitis in a Patient Receiving Alectinib for ALK-Positive Non–Small-Cell Lung Cancer: Histologic Analysis
|
Zhu, Viola W.
|
|
2019
|
20 |
1 |
p. e77-e80
|
artikel
|
| 21 |
Significance of 18F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non–small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy
|
Kim, Eunji
|
|
2019
|
20 |
1 |
p. e9-e23
|
artikel
|
| 22 |
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis
|
Scotti, Vieri
|
|
2019
|
20 |
1 |
p. e53-e61
|
artikel
|
| 23 |
Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib
|
Kauffmann-Guerrero, Diego
|
|
2019
|
20 |
1 |
p. 59-62
|
artikel
|
| 24 |
Table of Contents
|
|
|
2019
|
20 |
1 |
p. A5-A9
|
artikel
|
| 25 |
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations
|
Lam, Vincent K.
|
|
2019
|
20 |
1 |
p. 30-36.e3
|
artikel
|
| 26 |
The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma
|
Zhu, You-cai
|
|
2019
|
20 |
1 |
p. e73-e76
|
artikel
|
Tijdschrift beschrijving